Riskpilot← Back to searchSign inGet full accessAPOTEKET BRAKERØYA AS
ASActiveOrg 918565248Brandtenborggata 1, 3012 DrammenRetail sale of pharmaceutical products · NACE 4773Est. 201720 employees
Revenue 2022
NOK 25,4M
+25% vs 2021
EBITDA margin
10.3%
+86% vs 2021
Equity ratio
50.4%
Financial strength
Net profit 2022
NOK 1,9M
+96% vs 2021
| Revenue | NOK 25,4M | +25% |
| EBITDA | NOK 2,6M | +86% |
| Net profit | NOK 1,9M | +96% |
| Total assets | NOK 6,9M | +20% |
| Equity | NOK 3,5M | +123% |
| Employees | 20 | — |
Legal name
APOTEKET BRAKERØYA AS
Org number
918565248
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
15. februar 2017
Share capital
NOK 30 000
Employees
20 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive apotek, utleie av apoteks personal, salg av helseprodukter, organiske, økologiske produkter, konsulentvirksomhet, kurs og annet som naturlig faller sammen med dette som at delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Brandtenborggata 1, 3012 Drammen
Phone
+4732824500
Email
kontakt@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 12 746 | 13 540 | 17 147 | 20 336 | 25 402 |
| Staff expenses | −2 711 | −2 818 | −2 213 | −2 975 | −2 315 |
| EBITDA | −261 | 45 | 2 124 | 1 406 | 2 618 |
| Depreciation & amort. | −190 | −157 | −157 | −146 | −152 |
| EBIT | −451 | −112 | 1 967 | 1 260 | 2 465 |
| Net financials | −72 | −62 | −48 | −0 | 0 |
| Profit before tax | −524 | −174 | 1 919 | 1 260 | 2 465 |
| Tax | −0 | −0 | 155 | 277 | 542 |
| Net profit | −524 | −174 | 1 764 | 983 | 1 923 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 3 439 | 2 895 | 3 439 | 5 743 | 6 912 |
| Equity | −1 012 | −1 186 | 578 | 1 561 | 3 484 |
| Long-term debt | 1 313 | 2 093 | 609 | 604 | 33 |
| Short-term debt | 3 138 | 1 988 | 2 252 | 3 578 | 3 395 |
| Total debt | 4 450 | 4 081 | 2 861 | 4 182 | 3 428 |
EBITDA margin
10.3%
This company
15.8%
Market median
-35% vs market
20182022
Equity ratio
50.4%
This company
38.2%
Market median
+32% vs market
20182022
Return on equity
55.2%
This company
18.4%
Market median
+200% vs market
20182022
Net profit margin
7.6%
This company
8.1%
Market median
-6% vs market
20182022
Asset turnover
3.68×
This company
1.12×
Market median
+229% vs market
20182022
Debt / equity
0.98×
This company
0.62×
Market median
+58% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Chairman | 2017 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arvans Holdingselskap As
APOTEKET BRAKERØYA AS Board members of APOTEKET BRAKERØYA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Børge Moholt | Chairman | 0 companies |
| Øystein Askim | Board of Directors | 0 companies |
| Amir Arvan | Chairman | 0 companies |